Home / Pharmaceutical company intelligence
Aspin Pharma logo
Pharmaceutical company intelligence

Aspin Pharma

Private pharmaceutical manufacturer · Karachi · Pakistan

Karachi-based pharmaceutical manufacturer with branded portfolios across gastroenterology, cardiology, neuropsychiatry, endocrinology and women’s health.

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation23 Sep 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date23 Jul 2026Newest effective date among published current price records
Corporate profile evidence5 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Legal / official name
Aspin Pharma (Pvt.) Ltd.
Company type
Private pharmaceutical manufacturer
Address
Plot No. 10 & 25, Sector 20, Korangi Industrial Area, Karachi 74900, Pakistan · 74900
Phone
+92 21 111 515 515; +92 21 35045560-62
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
100%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000045 Aspin Pharma (Pvt) Ltd. · Sindh
Basic Manufacture 000054 Aspin Pharma (Pvt) Ltd · Sindh Cancelled (273rd)
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000045 105 linked products · source seen 23 Sep 2026 View source ↗
Corporate profile source ledger Logo Url source ↗ Contact Page Url source ↗ Logo Source Url source ↗ Profile Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx105public portfolio records represented
REG79unique registrations represented
IDX105indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+0registry-only registrations
VER0registry-verified exact registrations
PKR105current validated price records
G44generic molecules in indexed catalogue
DF9dosage-form groups
TA10therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage100%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage100%
priced packs safely normalized per unit
Comparable-market coverage94%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixAspin PharmaShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/aspin-pharmaGenerated 24 Sep 2026Anti-infectives49 · 47%Hematology & thrombosis15 · 14%Endocrine & metabolic13 · 12%Reproductive & genitourinary7 · 7%Gastrointestinal & hepatology6 · 6%Oncology & immunology5 · 5%Cardiovascular4 · 4%Other therapeutic areas6 · 6%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioAspin PharmaDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/aspin-pharmaGenerated 24 Sep 2026105presentationsTablet72 · 69%Capsule10 · 10%Cream6 · 6%Gel6 · 6%Injection5 · 5%Suspension3 · 3%Other forms3 · 3%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionAspin PharmaCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/aspin-pharmaGenerated 24 Sep 202699comparable productsBelow peer median29 · 29%Near peer median31 · 31%Above peer median39 · 39%Company median price position+2.4%Lowest-price equivalents5Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsAspin PharmaCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/aspin-pharmaGenerated 24 Sep 2026Nabiqasim Industries (Pvt) Ltd.,29 shared66% overlapM/s. Genix Pharma (Pvt) Ltd.27 shared61% overlapAtco Laboratories Limited27 shared61% overlapCCL Pharmaceuticals (Pvt.) Limited26 shared59% overlapGlobal Pharmaceuticals (Pvt.) Ltd.26 shared59% overlapGenome Pharmaceuticals (Pvt.) Ltd.26 shared59% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives49 products · 47%
Hematology & thrombosis15 products · 14%
Endocrine & metabolic13 products · 12%
Reproductive & genitourinary7 products · 7%
Gastrointestinal & hepatology6 products · 6%
Oncology & immunology5 products · 5%
Cardiovascular4 products · 4%
Vitamins, minerals & nutrition3 products · 3%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Antidiabetic medicines13 products · 12%
Antivirals11 products · 10%
Anticoagulants11 products · 10%
Antifungals8 products · 8%
Antimalarials5 products · 5%
Antiemetics5 products · 5%
Antiseptics & disinfectants5 products · 5%
Immunosuppressants / immunomodulators5 products · 5%
Formulation footprint

Dosage forms

Tablet72 products
Capsule10 products
Cream6 products
Gel6 products
Injection5 products
Suspension3 products
Drops1 products
Ointment1 products
Solution1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 BaroxaRivaroxaban 11presentations 10 mg, 15 mg, 2.5 mg, 20 mg · Tablet #2 EmaxyEmpagliflozin 8presentations 10 mg, 25 mg · Tablet #3 OndasetOndansetron 5presentations 4 mg, 4 mg/5 mL, 8 mg · Tablet, Solution #4 TaklidaTacrolimus 5presentations 0.5 mg, 1 mg, 5 mg · Capsule #5 ExermetMetformin 4presentations 1000 mg, 250 mg, 500 mg · Tablet #6 ObsaroxDeferasirox 4presentations 125 mg, 250 mg, 500 mg · Tablet
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median2929% of comparable products
Near market median31within ±5% of median
Above market median3939% of comparable products
Lowest-price equivalents5ties included
Company median price position +2.4% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
Aspinem 1 gMeropenem · Injection · 1's PKR 2,316.23/vial/unit-41.6% vs market median Aspinem 500 mgMeropenem · Injection · 1's PKR 1,239.18/vial/unit-40.3% vs market median Aspracin 200 mg/5 mLAzithromycin · Oral suspension · 15ml PKR 13.69/mL-31.8% vs market median Trimzol 10 mgClotrimazole · Cream · 10gm PKR 6.21/g-31.6% vs market median Morning Pill 0.75 mgLevonorgestrel · Tablet · 2's PKR 10.48/tablet-31.2% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Nabiqasim Industries (Pvt) Ltd.,365 products · 118 generics 29shared generics M/s. Genix Pharma (Pvt) Ltd.297 products · 97 generics 27shared generics Atco Laboratories Limited278 products · 94 generics 27shared generics CCL Pharmaceuticals (Pvt.) Limited249 products · 99 generics 26shared generics Global Pharmaceuticals (Pvt.) Ltd.224 products · 80 generics 26shared generics Genome Pharmaceuticals (Pvt.) Ltd.181 products · 84 generics 26shared generics
Regulatory & price activity

Observed database signals

Indexed registration numbers79Distinct registrations among indexed, published, presentation-validated products only
Verified price observations105
Products with a verified price105
Products with multiple price observations0
Source records with multiple versions105
Latest portfolio source check22 Sep 2026
Latest effective price date23 Jul 2026
Latest source observation23 Sep 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

79 unique registration(s) · 105 indexed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Amlohyp Amlodipine 2.5 mg Tablet 2 x10's 098592 PKR 91.56 PKR 4.58/tablet 17% below median
Amlohyp Amlodipine 5 mg Tablet 2 x10's 098593 PKR 168.60 PKR 8.43/tablet 22% below median
Amlohyp Amlodipine 10 mg Tablet 2 x10's 098594 PKR 245.37 PKR 12.27/tablet 31% below median
Artrine Artemether 40 mg Tablet 8's 100111 PKR 528.91 PKR 66.11/tablet 6% above median
Artrine Artemether + Lumefantrine 80 mg + 480 mg Tablet 6's 100112 PKR 667.52 PKR 111.25/tablet Near median
ArtrineTablet Artemether + Lumefantrine 20 mg + 120 mg Tablet 14's 100110 PKR 578.29 PKR 41.31/tablet 5% above median
Aspimox Moxifloxacin 400 mg Tablet 5's 097205 PKR 762.72 PKR 152.54/tablet 17% below median
Aspinem Meropenem 500 mg Injection 1's 116176 PKR 1,239.18 PKR 1,239.18/vial/unit 40% below median
Aspinem Meropenem 1 g Injection 1's 116177 PKR 2,316.23 PKR 2,316.23/vial/unit 42% below median
Aspracin Azithromycin 250 mg Tablet 1 x6's 098797 PKR 247.84 PKR 41.31/tablet 12% below median
Aspracin Azithromycin 500 mg Tablet 1 x6's 098798 PKR 445.87 PKR 74.31/tablet 13% below median
Aspracin Azithromycin 200 mg/5 mL Oral suspension 15ml 127978 PKR 205.38 PKR 13.69/mL 32% below median
Axovir Aciclovir 5% Cream 10gm 089006 PKR 336.96 PKR 33.70/g 8% below median
Baroxa Rivaroxaban 10 mg Tablet 14's 089303 PKR 7,892.47 PKR 563.75/tablet Near median
Baroxa Rivaroxaban 10 mg Tablet 1 x10's 089303 PKR 5,521.90 PKR 552.19/tablet Near median
Baroxa Rivaroxaban 15 mg Tablet 7's 089304 PKR 5,196.51 PKR 742.36/tablet 5% above median
Baroxa Rivaroxaban 15 mg Tablet 10's 089304 PKR 7,050.61 PKR 705.06/tablet Near median
Baroxa Rivaroxaban 15 mg Tablet 14's 089304 PKR 9,871.52 PKR 705.11/tablet Near median
Baroxa Rivaroxaban 20 mg Tablet 7's 089305 PKR 6,576.18 PKR 939.45/tablet 5% above median
Baroxa Rivaroxaban 20 mg Tablet 10's 089305 PKR 8,925.60 PKR 892.56/tablet Near median
Baroxa Rivaroxaban 20 mg Tablet 14's 089305 PKR 12,496.18 PKR 892.58/tablet Near median
Baroxa Rivaroxaban 2.5 mg Tablet 7's 100113 PKR 1,419.27 PKR 202.75/tablet Near median
Baroxa Rivaroxaban 2.5 mg Tablet 10's 100113 PKR 2,028.54 PKR 202.85/tablet Near median
Baroxa Rivaroxaban 2.5 mg Tablet 14's 100113 PKR 2,839.86 PKR 202.85/tablet Near median
Celedopa Methyldopa 250 mg Tablet 100's 114304 PKR 1,614.41 PKR 16.14/tablet Near median
DaktacortCream Hydrocortisone 2 % Cream 10gm 009084 PKR 185.68 PKR 18.57/g No comparator
Daktarin Oral Miconazole 20 mg/g Gel 20gm 009078 PKR 256.48 PKR 12.82/g 52% above median
DaktarinCream Miconazole 2 % Cream 10gm 005480 PKR 176.46 PKR 17.65/g 159% above median
Dasavir Daclatasvir 30 mg Tablet 28's 088251 PKR 5,549.14 PKR 198.18/tablet Near median
Dasavir Daclatasvir 60 mg Tablet 28's 088252 PKR 9,376.32 PKR 334.87/tablet Near median
Dasavir Daclatasvir 90 mg Tablet 28's 094796 PKR 13,533.95 PKR 483.36/tablet No comparator
Emaxy Empagliflozin 10 mg Tablet 30's 120368 PKR 2,781.46 PKR 92.72/tablet 12% above median
Emaxy Empagliflozin 10 mg Tablet 10's 120368 PKR 945.49 PKR 94.55/tablet 14% above median
Emaxy Empagliflozin 10 mg Tablet 14's 120368 PKR 1,324.50 PKR 94.61/tablet 14% above median
Emaxy Empagliflozin 10 mg Tablet 28's 120368 PKR 2,596.03 PKR 92.72/tablet 12% above median
Emaxy Empagliflozin 25 mg Tablet 30's 120369 PKR 3,329.60 PKR 110.99/tablet 11% above median
Emaxy Empagliflozin 25 mg Tablet 10's 120369 PKR 1,132.96 PKR 113.30/tablet 14% above median
Emaxy Empagliflozin 25 mg Tablet 14's 120369 PKR 1,585.33 PKR 113.24/tablet 14% above median
Emaxy Empagliflozin 25 mg Tablet 28's 120369 PKR 3,107.49 PKR 110.98/tablet 11% above median
Exermet Metformin 500 mg Tablet 5 x10's 098912 PKR 136.47 PKR 2.73/tablet Near median
Exermet Metformin 250 mg Tablet 10 x10's 098914 PKR 175.10 PKR 1.75/tablet 26% below median
Exermet Metformin 500 mg Extended-release tablet 5 x10's 098915 PKR 140.29 PKR 2.81/tablet 9% below median
Exermet Metformin 1000 mg Tablet 30's 107503 PKR 161.53 PKR 5.38/tablet 40% above median
ExermetTablet Metformin 850 mg Tablet 3 x10's 098913 PKR 132.35 PKR 4.41/tablet Near median
Fitzloc Levetiracetam 500 mg Tablet 10's 108915 PKR 1,072.68 PKR 107.27/tablet 13% above median
Fitzloc Levetiracetam 250 mg Tablet 10's 110473 PKR 586.49 PKR 58.65/tablet 6% above median
Flucoaid Fluconazole 150 mg Capsule 1's 100136 PKR 267.92 PKR 267.92/capsule Near median
Flucoaid Fluconazole 50 mg Capsule 7's 100137 PKR 873.67 PKR 124.81/capsule Near median
Gyno-Daktarin Miconazole 2 % Cream 20gm 004779 PKR 343.96 PKR 17.20/g 153% above median
Imodium Loperamide HCl 2 mg Capsule 6x10's 006159 PKR 397.83 PKR 6.63/capsule 30% above median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Aspin Pharma — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved September 24, 2026, from https://medinfobase.com/company/aspin-pharma/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.